Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms

被引：0
|
作者：
Orliaguet, Marie [1 ]
Boisrame, Sylvie [1 ]
Eveillard, Jean-Richard [2 ]
Pan-Petesch, Brigitte [2 ,3 ]
Couturier, Marie-Anne [2 ]
Rebiere, Vincent [2 ]
Guillerm, Gaelle [2 ]
Le Bousse-Kerdiles, Marie-Caroline [4 ,5 ]
Misery, Laurent [6 ]
Lippert, Eric [5 ,7 ,8 ]
Ianotto, Jean-Christophe [2 ,3 ,5 ]
机构：
[1] CHRU Brest, Dept Chirurg Orale, Brest, France
[2] CHRU Brest, Inst Cancerohematol, Serv Hematol Clin, Ave Foch, F-29609 Brest, France
[3] CHRU Brest, EA3878, Grp Etud Thromboses Bretagne Occidentale, GETBO, Brest, France
[4] Univ Paris XI, Inst Andre Lwoff, UMR S MD 1197, Villejuif, France
[5] France Intergrp Neoplasies Myeloproliferat FIM, Paris, France
[6] CHRU Brest, Serv Dermatol, Brest, France
[7] CHRU Brest, Lab Hematol, Brest, France
[8] Univ Brest, INSERM, UMR 1078, Brest, France
来源：
EJHAEM | 2020年 / 1卷 / 01期
关键词：
CHRONIC HEPATITIS-C; ALPHA-2B; TOXICITY;
D O I：
10.1002/jha2.15
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：350 / 352
页数：3
相关论文
共 50 条
  • [1] Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients
    Gowin, Krisstina
    Thapaliya, Prakash
    Samuelson, Jan
    Harrison, Claire
    Radia, Deepti
    Andreasson, Bjorn
    Mascarenhas, John
    Rambaldi, Alessandro
    Barbui, Tiziano
    Rea, Catherine J.
    Camoriano, John
    Gentry, Amy
    Kiladjian, Jean-Jacques
    O'Connell, Casey
    Mesa, Ruben
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (10): : 1570 - 1573
  • [2] Use of Pegylated Interferon in Six Pediatric Patients with Myeloproliferative Neoplasms
    Kucine, Nicole
    Bergmann, Shayla
    Krichevsky, Spencer
    Jones, Devin
    Rytting, Michael E.
    Resar, Linda
    Mascarenhas, John
    Verstovsek, Srdan
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [3] Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms
    Bahcecioglu, Adile Begum
    Etgul, Sezgin
    Aslan, Tuncay
    Aydin, Muruvvet Seda
    Malkan, Umit Yavuz
    Okay, Mufide
    Ozdemir, Evren
    Ciftciler, Rafiye
    Goker, Hakan
    Buyukasik, Yahya
    BLOOD, 2016, 128 (22)
  • [4] Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
    Ianotto, Jean-Christophe
    Chauveau, Aurelie
    Boyer-Perrard, Francoise
    Gyan, Emmanuel
    Laribi, Kamel
    Cony-Makhoul, Pascale
    Demory, Jean-Loup
    de Renzis, Benoit
    Dosquet, Christine
    Rey, Jerome
    Roy, Lydia
    Dupriez, Brigitte
    Knoops, Laurent
    Legros, Laurence
    Malou, Mohamed
    Hutin, Pascal
    Ranta, Dana
    Benbrahim, Omar
    Ugo, Valerie
    Lippert, Eric
    Kiladjian, Jean-Jacques
    HAEMATOLOGICA, 2018, 103 (03) : 438 - 446
  • [5] High molecular response rate of polycythemia vera patients treated with pegylated interferon α-2a
    Kiladjian, Jean-Jacques
    Cassinat, Bruno
    Turlure, Pascal
    Cambier, Nathalie
    Roussel, Murielle
    Bellucci, Sylvia
    Menot, Marie-Laurence
    Massonnet, Gerald
    Dutel, Jean-Luc
    Ghomari, Kamel
    Rousselot, Philippe
    Grange, Marie-Jose
    Chait, Yasmina
    Vainchenker, William
    Parquet, Nathalie
    Abdelkader-Aljassem, Lina
    Bernard, Jean-Francois
    Rain, Jean-Didier
    Chevret, Sylvie
    Chomienne, Christine
    Fenaux, Pierre
    BLOOD, 2006, 108 (06) : 2037 - 2040
  • [6] Pegylated Interferon Alpha-2a in 75 Patients with Myeloproliferative Neoplasms: A Single Center Experience
    Gowin, Krisstina L.
    Jain, Tania
    Kosiorek, Heidi E.
    Camoriano, John
    Tibes, Raoul
    Palmer, Jeanne
    Mesa, Ruben A.
    BLOOD, 2015, 126 (23)
  • [7] Combination therapy of pegylated interferon alpha 2a and ruxolitinib in myelofibrosis: a case report
    Hindilerden, F.
    Demiriz, I.
    LEUKEMIA RESEARCH, 2019, 85 : S48 - S48
  • [8] High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
    Tiziano Barbui
    Alessandro Maria Vannucchi
    Alberto Alvarez-Larran
    Alessandra Iurlo
    Arianna Masciulli
    Alessandra Carobbio
    Arianna Ghirardi
    Alberto Ferrari
    Giuseppe Rossi
    Elena Elli
    Marcio Miguel Andrade-Campos
    Mercedes Gasior Kabat
    Jean-Jaques Kiladjian
    Francesca Palandri
    Giulia Benevolo
    Valentin Garcia-Gutierrez
    Maria Laura Fox
    Maria Angeles Foncillas
    Carmen Montoya Morcillo
    Elisa Rumi
    Santiago Osorio
    Petros Papadopoulos
    Massimiliano Bonifacio
    Keina Susana Quiroz Cervantes
    Miguel Sagues Serrano
    Gonzalo Carreno-Tarragona
    Marta Anna Sobas
    Francesca Lunghi
    Andrea Patriarca
    Begona Navas Elorza
    Anna Angona
    Elena Magro Mazo
    Steffen Koschmieder
    Marco Ruggeri
    Beatriz Cuevas
    Juan Carlos Hernandez-Boluda
    Emma Lopez Abadia
    Blanca Xicoy Cirici
    Paola Guglielmelli
    Marta Garrote
    Daniele Cattaneo
    Rosa Daffini
    Fabrizio Cavalca
    Beatriz Bellosillo
    Lina Benajiba
    Natalia Curto-Garcia
    Marta Bellini
    Silvia Betti
    Valerio De Stefano
    Claire Harrison
    Leukemia, 2021, 35 : 485 - 493
  • [9] High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
    Barbui, Tiziano
    Vannucchi, Alessandro Maria
    Alvarez-Larran, Alberto
    Iurlo, Alessandra
    Masciulli, Arianna
    Carobbio, Alessandra
    Ghirardi, Arianna
    Ferrari, Alberto
    Rossi, Giuseppe
    Elli, Elena
    Andrade-Campos, Marcio Miguel
    Kabat, Mercedes Gasior
    Kiladjian, Jean-Jaques
    Palandri, Francesca
    Benevolo, Giulia
    Garcia-Gutierrez, Valentin
    Fox, Maria Laura
    Foncillas, Maria Angeles
    Morcillo, Carmen Montoya
    Rumi, Elisa
    Osorio, Santiago
    Papadopoulos, Petros
    Bonifacio, Massimiliano
    Cervantes, Keina Susana Quiroz
    Serrano, Miguel Sagues
    Carreno-Tarragona, Gonzalo
    Sobas, Marta Anna
    Lunghi, Francesca
    Patriarca, Andrea
    Elorza, Begona Navas
    Angona, Anna
    Mazo, Elena Magro
    Koschmieder, Steffen
    Ruggeri, Marco
    Cuevas, Beatriz
    Hernandez-Boluda, Juan Carlos
    Abadia, Emma Lopez
    Cirici, Blanca Xicoy
    Guglielmelli, Paola
    Garrote, Marta
    Cattaneo, Daniele
    Daffini, Rosa
    Cavalca, Fabrizio
    Bellosillo, Beatriz
    Benajiba, Lina
    Curto-Garcia, Natalia
    Bellini, Marta
    Betti, Silvia
    De Stefano, Valerio
    Harrison, Claire
    LEUKEMIA, 2021, 35 (02) : 485 - 493
  • [10] Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
    Teng, Guangshuai
    Zhang, Yuhui
    Du, Chenxiao
    Wang, Yan
    Hu, Naibo
    Han, Yingdi
    Ma, Jinyu
    Gao, Shan
    Xiang, Guangpeng
    Shao, Zonghong
    Bai, Jie
    BLOOD, 2022, 140 : 3959 - 3960
12345